ISIN | LU0432979614 |
---|---|
Valor Number | 10261626 |
Bloomberg Global ID | |
Fund Name | JPM Global Healthcare Fund A acc USD |
Fund Provider |
J.P. Morgan Bank Luxembourg S.A.
6, route de Trèves L-2633, Senningerberg Grand Duchy of Luxembourg |
Fund Provider | J.P. Morgan Bank Luxembourg S.A. |
Representative in Switzerland |
JPMorgan Asset Management (Switzerland) LLC Genève Phone: +41 22 744 11 11 |
Distributor(s) |
JP Morgan Asset Management (Europe) Sàrl Senningerberg Phone: +352 34 10 1 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally. |
Peculiarities |
Current Price * | 458.48 USD | 25.06.2025 |
---|---|---|
Previous Price * | 455.57 USD | 24.06.2025 |
52 Week High * | 557.48 USD | 03.09.2024 |
52 Week Low * | 437.54 USD | 15.05.2025 |
NAV * | 458.48 USD | 25.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 3,440,630,281 | |
Unit/Share Assets *** | 917,030,323 | |
Trading Information SIX |
YTD Performance | -2.04% |
31.12.2024 - 25.06.2025
31.12.2024 25.06.2025 |
---|---|---|
YTD Performance (in CHF) | -13.10% |
31.12.2024 - 25.06.2025
31.12.2024 25.06.2025 |
1 month | +1.42% |
27.05.2025 - 25.06.2025
27.05.2025 25.06.2025 |
3 months | -7.69% |
25.03.2025 - 25.06.2025
25.03.2025 25.06.2025 |
6 months | -3.27% |
27.12.2024 - 25.06.2025
27.12.2024 25.06.2025 |
1 year | -11.65% |
25.06.2024 - 25.06.2025
25.06.2024 25.06.2025 |
2 years | -1.15% |
26.06.2023 - 25.06.2025
26.06.2023 25.06.2025 |
3 years | -0.25% |
27.06.2022 - 25.06.2025
27.06.2022 25.06.2025 |
5 years | +16.41% |
25.06.2020 - 25.06.2025
25.06.2020 25.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 7.60% | |
---|---|---|
Johnson & Johnson | 6.91% | |
AbbVie Inc | 6.88% | |
AstraZeneca PLC | 4.93% | |
UnitedHealth Group Inc | 4.88% | |
Boston Scientific Corp | 4.38% | |
Stryker Corp | 3.55% | |
Danaher Corp | 3.24% | |
Sanofi SA | 3.16% | |
McKesson Corp | 3.02% | |
Last data update | 31.05.2025 |
TER *** | 1.69% |
---|---|
TER date *** | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.69% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |